Anti-Human CD137 mAb-T&L T&L

Product Information

Background

4-1BB, also known as CD137, is an inducible cell surface receptor and one member of tumor necrosis factor receptor (tumor necrosis factor receptor, TNFR) superfamily. CD137 is encoded by the tumor necrosis factor receptor superfamily member 9 (TNFRSF9) gene and widely expressed on the surface of activated T cells and NK cells. Its ligand, CD137L, also a TNFSF member, is an inducible costimulatory receptor expressed by activated CD4 + and CD8 + T cells, NKT, NK cells, DC, macrophages, eosinophils, neutrophils and mast cells, especially on CD8 + T cells. CD137 / CD137L mediate immune responses by transmitting activation, proliferation, or apoptotic signals between immune cells.
The activation of CD137 can stimulate NK cell and T cell proliferation and generate anti-tumor activity, which induces durable memory responses. 4-1BB mAb can activate 4-1BB to recruit TNFR related factors TRAF1 and TRAF2. Then, TRAF1 and TRAF2 form a heterotrimer, which strengthens signal transduction through c-Jun N terminal kinase (JNK) or extracellular signal-regulated kinase (ERK) pathway. This heterotrimer can stimulate the proliferation of T cells and antigen-presenting cells, improve anti-tumor immune response of the body and secrete cytokines through the transcription of NF-κB.

References

1. Langstein J,Schwarz H. Identification of CD137 as a potent monocyte survival factor. Journal of leukocyte biology, 1999 , 65(6):829-833.

2. Kim,Hongheea ,wack K, yubum K, Beomb,Lee, Zang heea. Activation of c-Jun N-terminal Kinase by 4-1BB (CD137), a T Cell Co-stimulatory Molecule. Molecules and cells, 2000,10(3): 247-252.

3. Kienzle G, von Kempis J. CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. International immunology. 2000,12(1): 73-82.

Document

Anti-Human CD137 mAb

Anti-Human CD137 mAb_SDS

Anti-Human CD137 mAb_COA